BioTime (BTX) Tops Q2 EPS by 5c

BioTime (NYSE: BTX) reported Q2 EPS of ($0.03), $0.05 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $557 thousand.

For earnings history and earnings-related data on BioTime (BTX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• AeroVironment (AVAV) Tops Q4 EPS by 36c
• Berenberg Starts Brooks Macdonald Group PLC (BRK:LN) at Buy